Incidence of adverse events in patients with metastatic breast cancer during use of standard and on/off capecitabine protocols. RSD [Internet]. 2022 Jun. 7 [cited 2025 Dec. 5];11(8):e3711830426. Available from: https://rsdjournal.org/rsd/article/view/30426